Close
CDMO Safety Testing 2026
Novotech

Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...
- Advertisement -

Emmesย โ€“ a global, full-service Contract Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announces that it will introduce to market its third generation version ofย Advantage eClinicalย atย Society for Clinical Trials (SCT) in San Diego, May 15thย โ€“ 18th.ย The cloud platform of Advantage eClinical will be available as a standalone software product after undergoing more than two years of development. The system has been specifically designed to provide fast study builds, greater flexibility, and insights to clinical trial sponsors of all sizes.

Advantageย eClinical provides a fully integrated suite of data management applications backed by decades ofย domainย expertise.ย  The cloud platform includes apps for study design,ย electronic data capture (EDC), randomization and trial supply management (RTSM), patient-reported outcomes (ePRO), safety data and reporting, risk-based monitoring, source data verification, and specimen/shipment tracking.ย It will be offered as partย of combined packages with data consultation services, or simply as a standalone software product.

โ€œOne of the challenges many smaller biotechs face in the market is they donโ€™t have access to an integrated technology platform for their trials. Options are incredibly limited and expensive, and they are often inflexible and lack support. This is exactly what we have set out to address with our third-generation Advantage eClinical platform,โ€ย commentedย Hemang Maniar, Chief Information Officerย at Emmes.

Advantage eClinical was developed by clinicians for clinicians and provides one of the most cost competitive and resource rich options available to sponsors.ย  It delivers robust features that improve data quality, ease oversight of clinical trial operations, and reduce trial timelines and costs. The cloud platform builds on Advantage eClinicalโ€™s long history of supporting over 1,000 clinical trials, including several high-profile adaptive COVID-19 trials, and leverages these prior study designs as clone templates to empower customers with an expedited set-up.

Maniar added,ย โ€œas a cloud-based multi-tenant system it is easier to ensure scalability, security and release updates quickly. Whatโ€™s more, out of the box CDASH CRF libraries allow us to get studies up and running in only a few weeks. This addresses a major concern from sponsors who need to start collecting data ASAP to avoid any delays on trials. What we are also providing is tremendous flexibility, and the client can choose to build their modules alone or engage our experienced data teams to provide guidance. The combination of an integrated system built by experienced clinicians, flexible support, and cost-effective scale is unique in the current marketplace.โ€

Advantage eClinical has supported over 1,000 trials, for nearly one million patients in over 70ย countries, spanning more than 31,000 clinical trial sites.

Latest stories

Related stories

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...

BIO Asia – Taiwan 2026 to be Held in Mid-July in Taipei

Focusing on AI Integration to Unlock Opportunities for Accelerating...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป